Cogent Biosciences, Inc. (COGT)
NASDAQ: COGT · Real-Time Price · USD
36.34
-0.26 (-0.72%)
At close: Apr 28, 2026, 4:00 PM EDT
36.34
0.00 (0.00%)
After-hours: Apr 28, 2026, 5:42 PM EDT
Cogent Biosciences Market Cap
Cogent Biosciences has a market cap or net worth of $5.85 billion as of April 28, 2026. Its market cap has increased by 1,142.87% in one year.
Market Cap
5.85B
Enterprise Value
5.23B
1-Year Change
1,142.87%
Ranking
Category
Stock Price
$36.34
Market Cap Chart
Since July 10, 2020, Cogent Biosciences's market cap has increased from $124.27M to $5.85B, an increase of 4,609.57%. That is a compound annual growth rate of 94.23%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Belite Bio | 6.34B |
| Apogee Therapeutics | 6.32B |
| Terns Pharmaceuticals | 6.11B |
| Centessa Pharmaceuticals | 6.10B |
| Spyre Therapeutics | 6.01B |
| Rhythm Pharmaceuticals | 5.85B |
| Celcuity | 5.85B |
| Immunovant | 5.82B |